1. Efficacy and safety of nusinersen in infants with spinal muscular atrophy (SMA): Final results from the phase 3 ENDEAR study. (June 2017) Authors: Finkel, R.; Kuntz, N.; Mercuri, E.; Chiriboga, C.A.; Darras, B.; Topaloglu, H.; Montes, J.; Su, J.; Zhong, Z.J.; Gheuens, S.; Bennett, C.F.; Schneider, E.; Farwell, W. Journal: European journal of paediatric neurology Issue: Volume 21(2017)Supplement 1 Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗